Cannabigerol (CBG) Cannabinoid Research

Cannabigerol (CBG) Research Dashboard


Primary Studies


Related Studies


Total Studies

Clinical Studies


Clinical Meta-analyses


Double-blind Clinical Trials


Clinical Trials

Pre-Clinical Studies




Animal Studies


Laboratory Studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 161 studies associated with Cannabigerol (CBG).

Here is a small sampling of Cannabigerol (CBG) studies by title:

Components of the Cannabigerol (CBG) Research Dashboard

  • Top medical conditions associated with Cannabigerol (CBG)
  • Proven effects in clinical trials for Cannabigerol (CBG)
  • Receptors associated with Cannabigerol (CBG)
  • Individual study details for Cannabigerol (CBG)

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Cannabigerol (CBG)

Description of Cannabigerol (CBG)

Cannabigerolic acid (CBGA) is the precursor to cannabigerol (CBG). CBGA was isolated and characterized by R. Mechoulan and Y. Gaoni in 1965.

CBG is a non-psychoactive cannabis constituent (R. Mechoulam et al., 1970).

It is the central biosynthetic precursor to many cannabinoids. Therefore, CBG is often referenced as the "mother of all cannabinoids."

CBD is generally considered a safe phytocannabinoid.

Other Names:


Geranylolivetol plus numerous other supplier-based synonyms.

IUPAC Name: 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol

Molecular Formula: C21H32O2


Cannabigerol (CBG) Properties and Effects

Only Members can view Properties and Effects information. See DEMO page.

Cannabigerol (CBG) Receptor Binding

Only Members can view Receptor Binding information. See DEMO page.

Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.